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MembraneLipid membrane and lipopolysaccharide (LPS) interactions were investigated for a series of amphiphilic and
cationic peptides derived from human heparin cofactor II (HCII), using dual polarization interferometry,
ellipsometry, circular dichroism (CD), cryoTEM, and z-potential measurements. Antimicrobial effects of
these peptides were compared to their ability to disorder bacterial lipid membranes, while their capacity
to block endotoxic effects of LPS was correlated to the binding of these peptides to LPS and its lipid A moiety,
and to charge, secondary structure, and morphology of peptide/LPS complexes. While the peptide KYE28
(KYEITTIHNLFRKLTHRLFRRNFGYTLR) displayed potent antimicrobial and anti-endotoxic effects, its truncated
variants KYE21 (KYEITTIHNLFRKLTHRLFRR) and NLF20 (NLFRKLTHRLFRRNFGYTLR) provide some clues on
structure–activity relations, since KYE21 retains both the antimicrobial and anti-endotoxic effects of KYE28
(although both attenuated), while NLF20 retains the antimicrobial but only a fraction of the anti-endotoxic
effect, hence locating the anti-endotoxic effects of KYE28 to its N-terminus. The antimicrobial effect, on the
other hand, is primarily located at the C-terminus of KYE28. While displaying quite different endotoxic ef-
fects, these peptides bind to a similar extent to both LPS and lipid A, and also induce comparable LPS scaveng-
ing on model eukaryotic membranes. In contrast, fragmentation and densiﬁcation of LPS aggregates, in turn
dependent on the secondary structure in the peptide/LPS aggregates, correlate to the anti-endotoxic effect of
these peptides, thus identifying peptide-induced packing transitions in LPS aggregates as key for
anti-endotoxic functionality. This aspect therefore needs to be taken into account in the development of
novel anti-endotoxic peptide therapeutics.
© 2013 Published by Elsevier B.V.1. Introduction
As key components in the innate immune system, antimicrobial
and host defense peptides play a central role in the defense against
invading microbes. Such peptides provide direct broad-spectrum an-
timicrobial effects, but also a range of additional functionalities, in-
cluding anti-inﬂammatory and immune modulating effects, as well
as effects on angiogenesis and chemotaxis [1–3]. As part of our efforts
to clarify the role of such peptides, we previously identiﬁed a number
of peptides derived from different coagulation factors, including
thrombin [4], and other coagulation factors from the S1 peptidase
family [5,6]. These displayed direct antimicrobial action, but also
anti-endotoxic effects, the latter evidenced from both cell experi-
ments on macrophages, and results in animal models of septic
shock induced by lipopolysaccharide (LPS) or Gram-negative bacte-
ria. However, while demonstrating promising biological performance,
these previous studies [5,6] did not clarify the mode-of-action of
these peptides, nor the potential role of LPS and lipid A neutralization.46 184714377.
. Malmsten).
sevier B.V.Through its phosphate and carboxyl groups, LPS is a negatively
charged lipopolysaccharide, which constitutes a major component
of the outer membrane in Gram-negative bacteria [7]. It is anchored
to the outer leaﬂet of this membrane through its hydrophobic lipid
moiety (lipid A), while a short oligosaccharide moiety (R-core) and
an outer polymeric carbohydrate (O-antigen) region extend into the
surrounding aqueous solution [7,8]. Although there are previous re-
ports in literature on how peptide length, hydrophobicity, charge,
and secondary structure affect their anti-endotoxic effects [7,9–15],
studies on the detailed peptide–LPS interactions are scarce, e.g., re-
garding the relative importance of peptide binding to LPS, its lipid A
moiety, and lipid membranes, and regarding peptide effects on LPS
aggregate morphology.
Considering this, we here report on such investigations for KYE28
(KYEITTIHNLFRKLTHRLFRRNFGYTLR), a peptide derived from helix D
of heparin cofactor II (HCII) [16]. In order to enable mechanistic inter-
pretation, results with this peptide are compared to those for two
truncated peptides of KYE28, i.e., KYE21 (KYEITTIHNLFRKLTHRLFRR)
and NLF20 (NLFRKLTHRLFRRNFGYTLR). These truncated peptides
are interesting for structure–activity investigations, since KYE21 re-
tains both the antimicrobial and anti-endotoxic effects of KYE28
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but only a fraction of the anti-endotoxic effect. The peptides were in-
vestigated regarding lipid membrane binding and disruption, but also
with respect to their interaction with LPS and lipid A, as well as second-
ary structure, z-potential, and morphology of LPS/peptide complexes,
using a method combination of dual polarization interferometry (DPI),
ellipsometry, circular dichroism spectroscopy (CD), z-potential mea-
surements, and cryoTEM. The biophysical results thus obtained are
correlated to results on antimicrobial and anti-endotoxic properties of
these peptides.
2. Experimental
2.1. Chemicals
Peptides (Table 1) were synthesized by Biopeptide Co., San Diego,
USA, and were of N95% purity, as evidenced by mass spectral analysis
(MALDI-TOF Voyager). LPS from E. coli (0111:B4) and lipid A from
E. coli F583 (Rd mutant) were both from Sigma (St. Louis, USA),
while 1-anilinonaphthalene-8-sulfonic acid (ANS) (N97%) was from
Sigma-Aldrich (St. Louis, USA).
2.2. Microorganisms
Escherichia coli ATCC 25922 was obtained from the Department of
Clinical Bacteriology at Lund University Hospital, Sweden.
2.3. Viable-count analysis
E. coli ATCC 25922 was grown to mid-logarithmic phase in Todd–
Hewitt (TH) medium. Bacteria were washed and diluted in 10 mM
Tris, pH 7.4, 5 mM glucose, and 0.15 M NaCl. 50 μl of 2 × 106 cfu/ml
bacteria were incubated at 37 °C for 2 h in the presence of peptide
at the indicated concentrations. Serial dilutions of the incubation
mixture were plated on TH agar, followed by incubation at 37 °C
overnight and cfu determination.
2.4. LPS effects on macrophages in vitro
Cells used were RAW 276.4 (ATCC TIB 71, American Type Culture
Collection, Manassas, USA). 3.5 × 105 cells were seeded in 96-well
tissue culture plates (Nunc, 167008) in phenol red-free DMEM
(Gibco) supplemented with 10% FBS and antibiotics (Gibco® antibiotic–
antimycotic, containing 10,000 units/ml of penicillin, 10,000 μg/ml of
streptomycin, and 25 μg/ml of Fungizone®). Following 6 h of incuba-
tion to permit adherence, cells were stimulated with 10 ng/ml E. coli
LPS (0111:B4) (Sigma, St. Louis, USA), with and without peptide of var-
ious doses. The levels of NO in culture supernatants were determined
after 24 h from stimulation using the Griess reaction [17]. Brieﬂy, ni-
trite, a stable product of NO degradation, was measured by mixing
50 μl of culture supernatants with the same volume of Griess reagent
(Sigma, G4410) and reading absorbance at 550 nm after 15 min.
Phenol-red free DMEM with FBS and antibiotics were used as a blank.
A standard curve was prepared using 0–80 μM sodium nitrite solutionsTable 1
Sequence and key properties of the peptides investigated.
Sequence IP1 Znet2 (pH 7.4) H3
KYE28 KYEITTIHNLFRKLTHRLFRRNFGYTLR 11.86 +6 −0.72
KYE21 KYEITTIHNLFRKLTHRLFRR 11.97 +5 −0.79
NLF20 NLFRKLTHRLFRRNFGYTLR 12.58 +6 −0.80
1 IP:isoelectric point.
2 Znet: net charge.
3 H mean hydrophobicity on the Kyte–Doolittle scale [59].in ddH20. In addition, RAW-Blue cells (InvivoGen, SanDiego, USA)were
stimulated with 10 ng/ml E. coli LPS (0111:B4) together with the
indicated peptide concentrations for 20 h. Measurement of NF-κΒ acti-
vation was subsequently performed according to the manufacturer's
protocol.2.5. Liposome preparation and leakage assay
Model liposomes investigated were either anionic (DOPE/DOPG
75/25 mol/mol) or zwitterionic (DOPC/cholesterol 60/40 mol/mol).
DOPE/DOPG is extensively used as a model system in the AMP litera-
ture, and has been previously demonstrated by us and others to give
similar results regarding peptide interactions as E. coli lipid extract
membranes [18]. In contrast to the latter, DOPE/DOPG offers method-
ological advantages. Because of the long, symmetric, and unsaturated
acyl chains of these phospholipids, membrane cohesion is good,
which facilitates stable, unilamellar, and largely defect-free liposomes
and well deﬁned supported lipid bilayers, allowing detailed data
on leakage and adsorption density to be obtained. Similar concerns mo-
tivated the use of (60/40) DOPC/cholesterol membranes, extensively
used as eukaryotic cell mimic in literature [19]. DOPG (1,2-dioleoyl-sn-
glycero-3-phosphoglycerol, monosodium salt), DOPE (1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine), and DOPC (1,2-dioleoyl-sn-glycero-
3-phosphocholine) were all from Avanti Polar Lipids (Alabaster, USA)
and of N99% purity, while cholesterol (N99%) was from Sigma-Aldrich
(St. Louis, USA). In addition, reconstituted lipid membranes were used
based on polar extract of Escherichia coli (E. coli) with a lipid composi-
tion of 67.0% phosphatidylethanolamine, 23.2% phosphatidylglycerol,
and 9.8% diphosphatidylglycerol (Avanti Polar Lipids; Alabaster,
USA). The lipid mixture was dissolved in chloroform, after which the
solvent was removed by evaporation under vacuum overnight. Subse-
quently, 10 mM Tris buffer, pH 7.4, was added together with 0.1 M
carboxyﬂuorescein (CF) (Sigma, St. Louis, USA). After hydration, the
lipid mixture was subjected to eight freeze–thaw cycles, consisting of
freezing in liquid nitrogen and heating to 60 °C (except for E. coli
liposomes, since these cannot withstand such cycling). Unilamellar
liposomes of about Ø140 nm were generated by multiple extrusions
(30 passages) through polycarbonate ﬁlters (pore size 100 nm)
mounted in a LipoFast miniextruder (Avestin, Ottawa, Canada) at
22 °C. Untrapped CF was removed by two subsequent gel ﬁltrations
(Sephadex G-50, GE Healthcare, Uppsala, Sweden) at 22 °C, with Tris
buffer as eluent. CF release from the liposomes was determined bymon-
itoring the emitted ﬂuorescence at 520 nm from liposome dispersion
(10 μM lipid in 10 mM Tris, pH 7.4). For the leakage experiment in the
presence of LPS, 0.02 mg/ml LPS was ﬁrst added to the above liposome
dispersion (which did not cause liposome leakage in itself; results not
shown), after which peptide was added and leakage monitored as a
function of time. An absolute leakage scale was obtained by disrupting
the liposomes at the end of each experiment through addition of
0.8 mM Triton X-100 (Sigma-Aldrich, St. Louis, USA). A SPEX-ﬂuorolog
1650 0.22-m double spectrometer (SPEX Industries, Edison, USA) was
used for the liposome leakage assay. Measurements were performed in
triplicate at 37 °C.2.6. Fluorescence spectroscopy
ANS ﬂuorescence spectra were determined by a SPEX-ﬂuorolog-2
spectroﬂuorometer at an ANS concentration of 10 μM. A slit width of
1 nm at both excitation and emission, and an excitation wavelength
of 360 nmwere used, while emission spectra were recorded between
370 and 600 nm [20]. Measurements were conducted at 37 °C while
stirring in either 10 mM Tris, pH 7.4. Where indicated, LPS (0.2 mg/ml),
peptide (10 or 50 μM) or their combination was included. Data reported
refer to limiting spectra after one hour of equilibration.
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Circular dichroism (CD) spectra were measured by a Jasco J-810
spectropolarimeter (Jasco, Easton, USA). Measurements were performed
in duplicate at 37 °C in a 10 mm quartz cuvette under stirring with a
peptide concentration of 10 μM. The effect on peptide secondary struc-
ture of liposomes at a lipid concentration of 100 μM was monitored in
the range 200–260 nm. The α-helix content was calculated from the
recorded CD signal at 225 nm using reference peptides in purely helical
and random coil conformations, respectively. 100% α-helix and 100%
random coil references were obtained from 0.133 mM (monomer con-
centration) poly-L-lysine (Mw = 79 kDa) in 0.1 M NaOH and 0.1 M
HCl, respectively. For measurements in the presence of LPS, 0.2 mg/ml
was used. To account for instrumental differences between measure-
ments, background correction was performed routinely by subtraction
of spectra for buffer (with or without liposomes/LPS) from spectra of
the corresponding samples in the presence of peptide.
2.8. Ellipsometry
Peptide adsorption to supported lipid bilayers was studied in situ by
null ellipsometry, using an Optrel Multiskop (Optrel, Kleinmachnow,
Germany) equipped with a 100 mW argon laser. All measurements
were carried out at 532 nm and an angle of incidence of 67.66° in a
5 ml cuvette under stirring (300 rpm). Both the principles of null
ellipsometry and the procedures used have been described extensively
before [21]. In brief, by monitoring the change in the state of polariza-
tion of light reﬂected at a surface in the absence and presence of an
adsorbed layer, the mean refractive index (n) and layer thickness (d)
of the adsorbed layer can be obtained. From the thickness and refractive
index the adsorbed amount (Γ) was calculated according to:
Γ ¼ n−n0ð Þ
dn=dc
d ð1Þ(a)
(b)
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Fig. 1. (a) Antimicrobial effect, as determined by viable count assay in 150 mM NaCl, 10 mM
rophages. RAW264.7 (left) or RAW-Blue (right) macrophages were incubated with LPS from
NO production or NF-κΒ activation, respectively.where n0 is the refractive index of the bulk solution (1.3347), and dn / dc
the refractive index increment (0.154 cm3/g). Corrections were routine-
ly done for changes in bulk refractive index caused by changes in tem-
perature and excess electrolyte concentration.
LPS-coated surfaces were prepared by adsorbing E. coli LPS to
methylated silica surfaces (surface potential, obtained from electroos-
mosis,−40 mV, contact angle 90° [22]) from 5 mg/ml LPS stock solu-
tion in water at a concentration of 0.4 mg/ml over a period of 2 h.
This results in a hydrophobically driven LPS adsorption of 1.48 ±
0.38 mg/m2, corresponding to plateau in the LPS adsorption isotherm
under these conditions, with an approximate area per acyl group of
200 Å2, assuming an LPS molecular weight of 104, and 6 acyl chains
per LPS. Non-adsorbed LPS was removed by rinsing with Tris buffer
at 5 ml/min for a period of 30 min, allowing buffer stabilization for
20 min. (The LPS surfaces thus obtained displayed similar peptide ad-
sorption as surfaces for which LPS was incorporated into preformed
DOPE/DOPG lipid bilayers (Fig. S1)). Peptide addition was performed
at different concentrations of 0.01, 0.1, 0.5, and 1 μM, and the adsorp-
tion monitored for one hour after each addition. All measurements
were performed at least in duplicate at 25 °C.
For lipid A deposition, this was solubilized with 0.25 wt.% triethyl
amine (TEA) under vigorous vortexing and heating to 60 °C for
10 min. Lipid A was adsorbed at methylated silica surfaces for 2 h
from 5 mg/ml lipid A stock solution in 0.25% TEA at a concentration
of 0.4 mg/ml in 10 mM Tris, pH 7.4, containing 150 mM NaCl.
Non-adsorbed lipid A was subsequently removed by rinsing with
the same buffer at 5 ml/min for 15 min, followed by buffer stabilization
for 20 min. This results in a lipid A adsorption of 0.8 ± 0.2 mg/m2. Pep-
tide addition was subsequently performed to 0.01, 0.1, 0.5, and 1 μM,
and adsorption monitored for one hour after each addition. (Absence
of transient maxima in the time-resolved adsorption curves after pep-
tide addition indicated competitive displacement to be unlikely for
the LPS and lipid A substrates). All measurements were performed at
least in duplicate at 25 °C.0
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Tris, pH 7.4, against Gram-negative E. coli. (b) Effects of the indicated peptides on mac-
E. coli in presence of peptides at the indicated concentration, followed by monitoring of
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DOPE/DOPG (75/25 mol/mol) or DOPC/cholesterol (60/40 mol/mol) li-
posomes were prepared as described above, but the dried lipid ﬁlms
resuspended in Tris buffer only with no CF present. In order to avoid
adsorption of peptide directly at the silica substrate (surface potential
−40 mV, contact angle b10° [22]) through any defects of the supported
lipid layer, poly-L-lysine (Mw = 170 kDa, Sigma-Aldrich, St. Louis,
USA) was preadsorbed from water prior to lipid addition to an amount
of 0.045 ± 0.01 mg/m2, followed by removal of nonadsorbed poly-
L-lysine by rinsing with water at 5 ml/min for 20 min [23]. Water in
the cuvette was then replaced by buffer containing also 150 mM NaCl,
followed by addition of liposomes in buffer at a lipid concentration
of 20 μM, and subsequently by rinsing with buffer (5 ml/min for
15 min) when the liposome adsorption had stabilized. The ﬁnal layer
formed had structural characteristics (thickness 4 ± 1 nm, mean re-
fractive index 1.47 ± 0.03), suggesting that a layer fairly close to a com-
plete bilayer is formed. After lipid bilayer formation, the cuvette content
was replaced by 10 mMTris buffer at a rate of 5 ml/min over a period of
30 min. After stabilization for 40 min, peptide was added to a concen-
tration of 0.01 μM, followed by three subsequent peptide additions to
0.1 μM, 0.5 μM, and 1 μM, in all cases monitoring the adsorption for
one hour. All measurements were made at least in duplicate at 25 °C.
2.9. Dual polarization interferometry
Peptide adsorption to DOPE/DOPG supported bilayers was also in-
vestigated by dual polarization interferometry (DPI), using a Farﬁeld
AnaLight 4D (Biolin Farﬁeld, Manchester, UK), operating with an(a)
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Fig. 2. Peptide-induced liposome leakage for DOPE/DOPG (75/25 mol/mol) in the ab-
sence (a) and presence (b) of 0.02 mg/ml E. coli LPS. Measurements were performed
in 10 mM Tris, pH 7.4.alternating 632.8 nm laser beam. The technique is based on a dual
slab waveguide, consisting of an upper sensing waveguide (supporting
the lipid bilayer) and a lower reference waveguide. The changes in-
duced by the peptide/lipid adsorptionweremonitored through changes
in the transverse electric and transverse magnetic modes as described
previously [24]. As for ellipsometry, Eq. (1) was used for determining
themass adsorbed. Although treating phospholipids as optically isotro-
pic systems is a reasonably accurate approximation for unsaturated and
disorganized phospholipid bilayers, these actually display some optical
birefringence, which is measurable with the sensitive DPI technique.
The birefringence (Δnf), obtained from the refractive indices for the
TM and TE waveguide modes (assuming the bilayer thickness to be
constant), reﬂects ordering of the lipidmolecules in the bilayer, and de-
creaseswith increasing disordering of the bilayer [25,26]. Consequently,
Δnf can be used to monitor disordering transitions in lipid bilayers,
e.g., as a result of peptide binding and incorporation, and therefore
offers a simpler alternative to, e.g., order parameter analyses in
2H-NMR spectroscopy [27]. In the present study, DOPE/DOPG liposomes
(75/25 mol/mol) were prepared as described above for ellipsometry, and
the liposomes (at a lipid concentration of 0.2 mg/ml in 10 mM HEPES
buffer, containing also 150 mM NaCl and 1.5 mM CaCl2) fused to the
silicon oxynitride/silicon substrate (contact angle b5°) at a ﬂow rate of
25 μl/min for 8 min. This resulted in bilayer formation, characterized
by a refractive index of 1.47, a thickness of 4.5 ± 0.3 nm, and an area
per molecule of 54 Å2. After bilayer formation, the buffer was changed
to 10 mM Tris buffer, allowing continuous ﬂushing (at ﬂow rate,(a)
(b)
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concentration. Peptide adsorption was monitored for 1 h. Measure-
ments were performed at least in duplicate at 25 °C.
2.10. Zeta potential measurements
Effective z-potential of E. coli. LPS and peptide–LPS aggregates
were determined by dynamic light scattering at a scattering angle of
173°, using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK)
and the Smoluchowski approximation. Peptide/LPS mixtures were
incubated for one hour before measurements were initiated, in each
case ensuring absence of time-dependent effects. Measurements
were performed in duplicate at 25 °C.
2.11. CryoTEM
Cryogenic transmission electron microscopy (cryoTEM) investiga-
tions were performedwith a Zeiss EM 902A transmission electron mi-
croscope (Carl Zeiss NTS, Oberkochen, Germany), operating at 80 kV
and in zero loss bright-ﬁeld mode. Digital images were recorded
under low dose conditions with a BioVision Pro-SM Slow Scan CCD
camera (Proscan GmbH, Scheuring, Germany) and analySIS software
(Soft Imaging System GmbH, Münster, Germany). In order to visual-
ize as many details as possible, an underfocus of 1–2 μM was used
to enhance the image contrast. The method for sample preparation
has been thoroughly described elsewhere [28]. In short, samples
were equilibrated at 25 °C and at close to 100% atmospheric humidity
within a climate chamber. A small drop (~1 μl) of sample was(a)
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Shown in Fig. 1a are results on the antimicrobial effects of KYE28,
KYE21, and NLF20, demonstrating potent antimicrobial effects for all
peptides. C-terminal truncation of KYE28 to KYE21 results in reduc-
tion of the antimicrobial effect, whereas N-terminal truncation to
NLF20 retains most, if not all, of the antimicrobial effect of KYE28
for the strain investigated. Furthermore, the peptides display varying
capacity to reduce LPS-induced NF-κΒ activation and NO production
in macrophages, KYE28 being more potent than KYE21, and NLF20
being the least potent of the peptides in this respect (Fig. 1b). Thus,
truncation of KYE28 to KYE21 reduces antimicrobial and anti-
endotoxic effects, but retains both, while truncation to NLF20 retains
most of the antimicrobial activity of KYE28, but only little of its
anti-endotoxic effect. Hence, anti-endotoxic and antimicrobial effects
of KYE28 are largely located in its C- and N-terminus, respectively.
As can be seen in Fig. 2, KYE28, KYE21, and NLF20 all display
concentration-dependent permeabilization of DOPE/DOPG lipo-
somes. Quantitatively, the more highly charged KYE28 and NLF20
are the most potent in causing membrane rupture, while KYE21 is
less so, the latter thus correlating with the antimicrobial results.
(Similar results were obtained also for liposomes prepared from
E. coli lipid extract (Fig. S2)). In the presence of LPS, leakage induction
in liposomes caused by all three peptides decreases, indicating that
these peptides bind to LPS with a higher afﬁnity than that for the
DOPE/DOPG membrane, in analogy, e.g., to previous ﬁndings for pep-
tides derived from S1 peptidases [6] and from granulysin [29]. As LPS
concentration used in the liposome leakage experiments was quite
high, the ﬁnding of the preferential binding to LPS over liposome
does not contradict the data on antimicrobial effects. Thus, in the lat-
ter experiments, LPS is present in lower concentration, hence LPS
binding will not deplete the peptide from solution. While there may
certainly be a barrier function of LPS in Gram-negative bacteria as
well [7], results on antimicrobial effects show that this barrier func-
tion is not sufﬁcient for preventing the fraction of peptides not
bound to LPS to incorporate into the bacteria membranes and disrupt
these.
As shown in Fig. 3, peptide binding to DOPE/DOPG bilayers reﬂects
their antimicrobial effect and liposome lysis capacity (KYE28 N
NLF20 N KYE21). In all cases, peptide binding results in an essentially
linear decrease in bilayer birefringence with increasing peptide incor-
poration (Fig. 3b). A comparable degree of membrane disorganization
is observed for KYE21 and NLF20, while KYE28 is more potently
disorganizing the lipid bilayer at a given amount of peptide bound.
For all peptides, the decrease in membrane birefringence starts al-
ready at the onset of peptide binding, which means that the peptides
are incorporated into the membrane (as opposed to sitting on top)
throughout the binding process. (In contrast, had a certain threshold
binding density been needed before triggering of peptide insertion,
Fig. 3b would have shown no initial change in birefringence with in-
creasing peptide binding, followed by a decrease in birefringence
above a certain threshold). This is analogous to results found for,
e.g., C-terminal peptides from S1 peptidases on DOPE/DOPG bilayers
[6], aurein 1.2 on E. coli extract and DMPE/DMPG bilayers [26], and
the C3a peptide CNY21L on DOPC mono- and bilayers [30], and
expected from the relatively high hydrophobicity of the peptides
investigated.
As shown in Fig. 4, all peptides display extensive binding to E. coli
LPS, as well as to its lipid Amoiety. Since the peptides investigated are
strongly positively charged and quite hydrophobic (Table 1), while
LPS carries a negative charge due to its phosphate and carboxylate
groups [8], and its lipid A moiety is obviously also hydrophobic,
these results are reasonable. In principle, quantitative “binding
afﬁnities” can be extracted from the adsorption isotherms, or from
the “on” and “off” rates on adsorption and desorption, respectively.
These ﬁtting parameters are, however, of uncertain physicochemicalmeaning, as it is unclear to what extent peptide binding to LPS is an
equilibrium process. In analogy to other hydrophobically modiﬁed
biopolymers, e.g., peptidoglycans [31], LPS is likely to interact with
the hydrophobic (θ ≈ 90°) and negatively charged (z ≈ −40 mV)
methylated silica surface through its lipid A moiety. At the relatively
high LPS densities reached in these experiments (1.4 mg/m2), the
lipid A moiety will therefore be at least partly screened by the LPS
carbohydrate chains, hence not fully accessible to peptide binding.
(cf similar peptide adsorption to membrane-bound LPS (Fig. S1)).
Since the carbohydrate moieties are much longer than lipid A, they
are expected to have a larger peptide binding capacity than lipid A,
as also previously demonstrated by Junkes et al. [32]. Despite this,
peptide binding is quite comparable for LPS and lipid A, suggesting
a higher binding afﬁnity of these peptides to lipid A. Finally, we
note a comparable adsorption at LPS and lipid A, despite these pep-
tides having quite different anti-endotoxic effects, arguing against
LPS “scavenging” as the sole anti-endotoxic mechanism for these
peptides.
Due to their net positive charge, another potential mode of action
of these peptides could be induction of localized LPS scavenging at
mammalian cell membranes. Thus, such cells (e.g., monocytes and
macrophages) have membranes rich in zwitterionic lipids [33], and
therefore carry a low negative charge. Adsorption of amphiphilic cat-
ionic peptides on such membranes may induce a net positive charge,
thus facilitating electrostatically driven LPS binding to these mem-
branes. Demonstrating this, Fig. 5a–b show that KYE28, KYE21, and
NLF20 all bind to DOPC/cholesterol membranes (mammalian mem-
brane mimic), resulting in a net positive potential of the membrane.
2715S. Singh et al. / Biochimica et Biophysica Acta 1828 (2013) 2709–2719Due to the positive charge, the adsorption of LPS to the peptide-
containing DOPC/cholesterol membrane increases (Fig. 5c). Thus, pep-
tide adsorption can induce localized membrane scavenging through
promoting an alternative binding site for LPS to macrophage/monocyte
membranes, competing with the inﬂammation-triggering binding to
LBP (LPS-binding protein) and CD14 (cf Discussion). Indeed, as seen in
Fig. 5c, NLF20, displaying the lowest anti-inﬂammatory effect of the
three peptides investigated, is also the peptide with the weakest capac-
ity for such localized LPS scavenging. Having said that, KYE28 and
KYE21 are quite comparable with regard to LPS binding promotion, de-
spite KYE28 being more potently anti-endotoxic. In conclusion, there-
fore, peptide-induced LPS scavenging localized at the eukaryotic cell
membrane may contribute to the anti-inﬂammatory effects displayed
by HCII peptides, but is not the sole factor involved.Fig. 7. Representative cryoTEM images of LPS (0.2 mg/ml in 10 mM Tris, pH 7.4) in the absen
showing the size distributions for the different systems are also included.CD experiments demonstrate that the peptides investigated are
largely disordered in buffer, with low (b15%) helix content. On bind-
ing to DOPE/DOPG liposomes, partial induction of ordered α-helix
and β-sheet structures is found for KYE28, and less so for the other
peptides (Fig. 6a and S3). In the presence of LPS, there is a pro-
nounced induction of α-helix/β-sheet for KYE28, but considerably
less so for KYE21 and NLF20 (Fig. 6b). A similar correlation between
anti-endotoxic effects and ordered structure formation in the LPS/
peptide aggregates was previously noted for S1 peptides [6], although
no mechanism was identiﬁed for this. However, cryoTEM shows that
the peptides investigated have dramatic effects on LPS aggregates,
which follow their anti-inﬂammatory effects. As seen in Fig. 7, LPS ag-
gregates are highly elongated and interconnected, most likely as a re-
sult of poor packing efﬁciency due to electrostatic repulsion between0
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2716 S. Singh et al. / Biochimica et Biophysica Acta 1828 (2013) 2709–2719the negatively charged carbohydrate domains of LPS, and the bulky
and partially charged nature of lipid A, both precluding efﬁcient pack-
ing in dense spherical micelles at these conditions. On addition of
KYE28, LPS aggregates initially disintegrate to short linear fragments,
and subsequently reorganize to form dense spherical particles at
higher peptide concentration (Fig. 7). Most likely, this fragmentation
and densiﬁcation is due to a reduction of the electrostatic repulsion
between negatively charged LPS chains through partial charge neu-
tralization, thereby facilitating denser packing. Similarly, peptide
binding in the vicinity of the lipid A phosphate group may facilitate
close packing. In comparison, KYE21 is less efﬁcient in fragmenting
LPS aggregates, and also results in (larger) spherical particles at
higher peptide concentration (Fig. 8). NLF20, ﬁnally, is even less efﬁ-
cient in rupturing and compacting LPS aggregates (Fig. 9). Correlating
this to the secondary structure of peptide/LPS aggregates, it seems
like helix formation facilitates increased packing density of the com-
posite aggregates, and that this in turn is correlated to the anti-
endotoxic effect of these peptides (KYE28 N KYE21 N NLF20).
To further characterize the LPS aggregate disruption process, ANS
ﬂuorescence spectroscopy was monitored. ANS is a ﬂuorescent probe,
which binds with high afﬁnity to hydrophobic regions of proteins and
other compounds. The ﬂuorescence spectrum of ANS reports on its
local environment, primarily ambient polarity. As seen in Fig. S4, the
ﬂuorescence spectrum of ANS is shifted to lower wavelengths in the
presence of LPS, demonstrating the localization of ANS to the hydro-
phobic lipid A moiety [20]. On peptide addition (10 μM), there is a
shift to higher wavelengths again, demonstrating that KYE28,
KYE21, and NLF20 all localize also to the lipid A moiety. At a peptide
concentration of 50 μM, there is a major increase in ﬂuorescence in-
tensity (Fig. 10), reﬂecting a dramatic transition in the lipid A moietyFig. 8. Representative cryoTEM images of LPS (0.2 mg/ml in 10 mM Tris, pH 7.4) in the prese
size distributions for the different systems are also included.of the LPS aggregates, mirroring the overall morphological change ob-
served with cryoTEM (Fig. 7–9). While cryoTEM shows LPS aggregate
fragmentation to occur already at 10 μM, the main transition in the
lipid A region occurs at the higher peptide concentration. As with
the overall morphological changes demonstrated by cryoTEM, the
peptide-induced packing transition in the lipid A region mirrors the
anti-endotoxic effect of these peptides.
4. Discussion
Given the barrier constituted by LPS for host defense peptides, as
well as its endotoxic effects, the interaction between such peptides
and LPS has attracted quite some interest in literature. For example,
Andrä et al. investigated the interaction between the antimicrobial
peptide NK-2 and LPS, and found both electrostatic and hydrophobic
interactions to be necessary for efﬁcient neutralization of the biolog-
ical activity of LPS [12]. These authors similarly found that C12 deriv-
atization of the lactoferricin-derived peptide LF11 results in enhanced
inhibition of LPS-induced cytokine generation [13]. In agreement
with the results obtained in the present investigations, Yang et al.
previously demonstrated that rALF-Pm3 binds similarly to LPS and
lipid A, and that attachment and detachment rates point to a higher
binding afﬁnity to lipid A compared to that at LPS [34]. Along the
same line, Brandenburg et al. employed FTIR to demonstrate that
lactoferrin binds preferentially to the phosphate groups of lipid
A [35], similar results also reported by Fukuoka et al. for
magainin 2-derived peptides [36]. This preference, however, seems
to be relatively marginal. For example, Junkes et al. showed that the
LPS binding of cyclic R- and W-rich peptides decreased on removal
of the O-antigen and outer polysaccharides from LPS, thus clearly0
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2717S. Singh et al. / Biochimica et Biophysica Acta 1828 (2013) 2709–2719demonstrating the importance of these moieties for peptide binding
as well [32]. As for other oppositely charged polyelectrolyte systems
[37–39], binding of cationic peptides (and similarly so with multiva-
lent cations) to the polysaccharide domain of LPS is expected to
lead to osmotic deswelling. For example, Schneck et al. investigated
the inﬂuence of Ca2+ on the conformation of Pseudomonas aeruginosa
LPS adsorbed to hydrophobic silanized silicon with specular X-ray re-
ﬂectivity, and found that presence of Ca2+ caused a collapse of the
negatively charged O-chains [8], analogous to similar effects found
for other membrane-bounds polysaccharides, such as proteoglycans0
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Fig. 10.Maximum ﬂuorescence intensity of ANS after addition of 10 or 50 μM of the in-
dicated peptides to 10 μM ANS and 0.2 mg/ml LPS in 10 mM Tris, pH 7.4.[31]. It is furthermore worth noting that small cationic peptides [35]
are able to penetrate deeply into LPS layers, all the way to the lipid
A moiety, to interact with its negatively charged phosphate groups.
Through this penetration of the LPS layers, ﬂuidization of the latter
has been noted, e.g., for a series of Pep19 peptide variants [40], a se-
ries of NK-lysine peptide variants [41], and polymyxin B [42]. It is
also worth noting that helix-induction of anti-endotoxic peptides
in the presence of LPS, as that found in the present investigation,
has previously been reported, e.g., for fowlicidin-1 fragments [43],
melittin [44], KmLn [15], as well as CAP18 [45] and SAMP-29 [46]
cathelicidins. While the helix-induction and resulting packing
changes were speculated to be related to the anti-endotoxic effect
of some of these peptides [43], in line with the results of the present
investigations and previous ﬁndings for S1 peptides [6], no mecha-
nism was provided.
With regard to the effects of anti-endotoxic peptides on LPS aggre-
gate charge and structure, it is worth noting that LPS aggregates have
been suggested to be responsible for its endotoxic effects. Addressing
this, Mueller et al. investigated well characterized lipid A analogs and
found that compositions favoring aggregate formation displayed en-
hanced endotoxic effects [47]. They also found that monomeric LPS,
prepared through dialysis, was largely inactive, while LPS aggregates
displayed pronounced endotoxic effects, clearly identifying LPS ag-
gregates as responsible for the endotoxic effect of LPS. It should be
noted, however, that LPS endotoxic effect has also been demonstrated
to be due to lipopolysaccharide-binding protein (LBP) promoting LPS
binding, as well as interaction with CD14 at monocyte and macro-
phage surfaces [48,49]. Subsequently, the LPS/LBP complex recog-
nizes CD14 and the Toll-like receptor 4 (TLR4) through the MD2
protein [50–52], resulting in an up-regulation of proinﬂammatory
2718 S. Singh et al. / Biochimica et Biophysica Acta 1828 (2013) 2709–2719cytokine production. Importantly, LBP has been shown to harbor a
lipid A-recognizing epitope, indicating that lipid A domains in LPS ag-
gregates are accessible to LBP binding, in agreement with the present
ﬁnding of quite open LPS aggregates. The correlation between the
lipid A ordering transition and the anti-endotoxic effect of peptides
has also been reported by Brandenburg et al. [41], Fukuoka et al.
[36], and Chen et al. [29]. However, no mechanistic description of
how such a structural transition is related to anti-endotoxic effects
has yet been presented. The present CD and cryoTEM results indicate
that the order transition of lipid A is correlated to larger scale packing
reorganizations (fragmentation/densiﬁcation) of LPS aggregates, that
peptide secondary structure facilitates such packing transitions, and
that the latter are correlated to the anti-inﬂammatory effect of the
presently investigated HCII peptides. A potential mechanism behind
this may be that LPS fragmentation, as well as reduction of the nega-
tive charge of LPS, facilitates phagocytosis, in analogy to size and
charge dependence of phagocytosis of other types of nanoparticular
systems. Through this, an alternative pathway to LPS–LBP/CD14
binding/activation is provided, resulting in attenuation, or even blocking,
of the inﬂammatory activation occurring in the absence of peptide.
Indeed, such phagocytosis-related scavenging as anti-inﬂammatory re-
sponse has been previously observed, although for inﬂammation caused
by amyloid Aβ rather than by LPS. Thus, Richman et al. investigated
protein-microspheres with an Aβ-recognizing peptide, and were able
to correlate anti-inﬂammatory effects of the latter with triggering of
Aβ phagocytosis, thereby avoiding the alternative triggering pathway
[53]. Along the same line, the cationic peptide LL-37 has been demon-
strated to transfer complexed negatively charged molecules into cells,
which has been used, e.g., to transfect eukaryotic cells [54]. The further
consequences of this for inﬂammatory cytokine generation, however,
remain unclear, as inhibition of TLR responses and of the generation of
inﬂammatory cytokines has been observed for myeloid cells [55],
whereas inﬂammatory activation was observed following peptide-
induced LPS cell internalization in the case of lung epithelial cells [56].
Thus, additional work on the phagocytosis of peptide/LPS aggregates,
as well as its correlation to peptide anti-endotoxic effects, is needed.
Here, much can potentially be learned from comparisons with the area
of particle phagocytosis, including effects of particle size, shape, and
charge [57,58].
5. Conclusions
Peptide interactions with bacterial LPS, its lipid A moiety, and lipid
membranes were investigated for KYE28 and its truncated peptide
variants KYE21 (retaining most of the antimicrobial and anti-
endotoxic effects of KYE28) and NLF20 (retaining the antimicrobial
but little anti-endotoxic effect). Bacterial killing by these peptides
correlates to peptide-induced membrane disordering and lysis. The
peptides all bind similarly to LPS and lipid A, with a higher peptide
binding afﬁnity than that of the lipid membrane. Since KYE28 (and
to a lesser extent KYE21), but not NLF20, displays powerful anti-
endotoxic effects, the latter are not due to simple LPS and lipid A
scavenging by these peptides. While peptide-induced LPS binding to
eukaryotic membranes was demonstrated to play a role for localized
LPS scavenging, the latter is not the sole mechanism of the anti-
endotoxic effects of these peptides. In contrast, a pronounced helix
formation was observed for the KYE28/LPS complex, but less so for
the less anti-endotoxic NLF20. These effects were found to depend
on peptide-induced fragmentation and densiﬁcation of LPS aggregates.
The latter effects therefore point to the importance of peptide-induced
LPS aggregate disruption for their anti-endotoxic function.
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bound to methylated silica or incorporated in DOPE/DOPG bilayers,
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